EcoDrugPlus

Transthyretin

Ensembl ID : ENSFCAG00000011314
Gene Symbol: TTR
5 Cross references
166 Possible Orthologues:

Tryptophan Hydroxylase 1

Ensembl ID : ENSFCAG00000025053
Gene Symbol: TPH1
5 Cross references
257 Possible Orthologues:

Tubulin Alpha 1a

Ensembl ID : ENSFCAG00000038056
Gene Symbol: TUBA1A
5 Cross references
116 Possible Orthologues:

Tubulin Alpha 1c

Ensembl ID : ENSFCAG00000037882
Gene Symbol: TUBA1C
5 Cross references
182 Possible Orthologues:

Tubulin Alpha 4a

Ensembl ID : ENSFCAG00000038881
Gene Symbol: TUBA4A
5 Cross references
225 Possible Orthologues:

Tubulin Alpha-3 Chain

Ensembl ID : ENSFCAG00000022091
Gene Symbol: LOC101090556
4 Cross references
149 Possible Orthologues:

Tubulin Beta 1 Class Vi

Ensembl ID : ENSFCAG00000014627
Gene Symbol: TUBB1
5 Cross references
186 Possible Orthologues:

Tubulin Beta 2b Class Iib

Ensembl ID : ENSFCAG00000014626
Gene Symbol: TUBB2B
5 Cross references
223 Possible Orthologues:

Tubulin Beta 3 Class Iii

Ensembl ID : ENSFCAG00000007697
Gene Symbol: TUBB3
3 Cross references
154 Possible Orthologues:

Tubulin Beta 4a Class Iva

Ensembl ID : ENSFCAG00000010269
Gene Symbol: TUBB4A
5 Cross references
89 Possible Orthologues:

Tubulin Beta 4b Class Ivb

Ensembl ID : ENSFCAG00000006465
Gene Symbol: TUBB4B
5 Cross references
74 Possible Orthologues:

Tubulin Beta 6 Class V

Ensembl ID : ENSFCAG00000033922
Gene Symbol: TUBB6
5 Cross references
141 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).